ダーマルフィラー(皮膚充填剤)の北米・欧州市場2016-2026

【英語タイトル】Dermal Filler Market: Clinics and Hospital Pharmacies Most Popular Distribution Segment: North America and Europe Industry Analysis and Opportunity Assessment, 2016-2026

Future Market Insightsが出版した調査資料(FMI703010)・商品コード:FMI703010
・発行会社(調査会社):Future Market Insights
・発行日:2016年11月11日
・ページ数:138
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:北米、欧州
・産業分野:医療
◆販売価格オプション(消費税別)
Individual (single user)USD5,000 ⇒換算¥535,000見積依頼/購入/質問フォーム
EnterpriseUSD10,000 ⇒換算¥1,070,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Dermal fillers are implants classified as medical devices by US FDA and are used in aesthetic procedures such as anti-aging, aesthetic corrections and facial contours. Dermal fillers are used for anti-aging practices for removal of wrinkles and folds in nasolabila, volume loss in chin and cheek area, lines and wrinkles around eye. Dermal fillers considered in the report include absorbable dermal fillers and non-absorbable dermal fillers depending upon their bio-degradability after injecting inside the dermal area below skin.
Based on the material used, there are five types of dermal fillers considered in the report which include hyaluronic acid (HA) based, poly-l-lactic acid (PLLA) based, calcium hydroxylapatite (CaHA) based, collagen based and polymethylmethacrylate (PMMA) based. Among those five types considered first four are absorbable while PMMA is non-absorbable. All the absorbable fillers are ingredients naturally present in the body and hence get broken down after certain period of time (3 to 24 months). The absorbable fillers may be animal derived, plant derived, bacteria derived or chemically derived. The non-absorbable fillers are chemically derived and last for up to five years. The quantity required for achieving the desired result varies, depending on type of filler and application area.

In terms of revenue, the North America and Europe dermal filler market is projected to register a CAGR of 6.4% during the forecast period and is expected to be valued at US$ 2,800.4 Mn by the end of 2026.

Rising demand for non-invasive aesthetic procedures and an increasing ageing population is driving the growth of the North America and Europe dermal filler market

Growth of North America and Europe dermal filler market is primarily driven by reasons such as aging population, increasing expenditure by public and private sources on healthcare, rising demand for non-invasive aesthetic procedures, introduction of novel application areas beside anti-aging like treatment of HIV induced facial lipoatrophy and enhancement of dorsal area of hand are expected to drive the North America and Europe dermal filler market. However, higher cost associated with the dermal filler procedure, patch up or reinjection needed for achieving the desired facial rejuvenation for absorbable dermal fillers and some post procedure complications associated with dermal fillers like bruising, redness and granulation are some factors expected to hamper growth of the North America and Europe dermal filler market over the forecast period.

Absorbable dermal filler product type segment dominated the North America and Europe dermal filler market in 2015

Absorbable filler product type segment is expected to witness relatively higher growth in terms of value in the North America and Europe dermal filler market over the forecast period. Also, in terms of revenue share, absorbable dermal filler product type segment dominated the North America and Europe dermal filler market in 2015 and is expected to continue its dominance throughout the forecast period.

Hyaluronic acid material type segment is expected to register a high CAGR during the forecast period

In terms of revenue share, hyaluronic acid material type segment dominated the North America and Europe dermal filler market in 2015 and is expected to maintain traction by 2026 end, registering a high CAGR as compared to other segments.

Clinics and hospital pharmacies distribution segment is the most popular and has a higher revenue share

Based on distribution channel, the market is segmented into retail pharmacies and drug Stores, clinics and hospital pharmacies and online sales. Currently, clinics and hospital pharmacies distribution segment accounts for relatively higher revenue share, followed by retail pharmacies and drug stores.

North America is expected to be the dominant regional market by 2016 end

The North America and Europe dermal filler market is segmented into three major regions: North America, Western Europe and Eastern Europe. In terms of value, North America is expected to be the dominant regional market by 2016 end, and is expected to register a CAGR of 6.5% over the forecast period. Western Europe is expected to be the fastest growing market in terms of revenue growth in the North America and Europe dermal filler market, registering a CAGR of 6.8% over the forecast period. Eastern Europe dermal filler market is expected to witness a CAGR of 5.1% over the forecasted period.

Key market players are focussing on expanding their geographic reach to enhance their market share

Some key players in the North America and Europe dermal filler market included in this report are Allergan Plc., Galderma Pharma S.A., Sinclair Pharma S.A., Anika Therapeutics Inc., Merz Pharma GmbH & Co. KGaA, Suneva Medical Inc., Teoxane Laboratories Inc., Prollenium Medical Technologies Inc., Laboratoires Vivacy S.A., Adoderm GmbH. Key players are focusing on establishing distribution agreements to increase their geographic reach. Moreover, companies are targeting small and local manufacturers of dermal fillers to increase their product portfolio and strengthen their geographic footprint. Also, new applications such as fillers for enhancement of dorsal area of hand and paralysed vocal cords treatment are influencing companies to adopt new strategies to enhance market share. The top companies dominating the North America dermal filler market are Allergan Plc., Galderma S.A, and Merz Pharma GmbH & Co. KGaA, who collectively contribute around 85% of the market.

【レポートの目次】

Table Of Content

1. Executive Summary

2. Dermal Filler Market Introduction

2.1. Dermal Filler Market Definition

2.2. Dermal Filler Market Product Defination

2.3. Dermal Filler Market Taxonomy

2.4. North America Dermal Filler Market, Snapshot

2.5. Western Europe Dermal Filler Market, Snapshot

2.6. Eastern Europe Dermal Filler Market, Snapshot

2.7. North America and Europe Dermal Filler Market Scenario Forecast

3. North America and Europe Dermal Filler Market, Analysis scenario 2016-2026

3.1. Price Forecast by Region

3.2. North America and Europe Dermal Filler Market Value forecast, 2016-2026

3.3. Value Chain

3.4. Parent Market Overview

4. North America and Europe Dermal Filler Market Dynamics

4.1. Macro Factors

4.2. Drivers

4.3. Restraints

4.4. Trends

4.5. Opportunity

4.6. Relevance and Impact

4.7. US FDA Regulatory Approval for Medical Devices

4.8. Europe Regulatory Approval for Medical Devices

4.9. Dermal Filler Market – Regulations

5. North America and Europe Dermal Filler Market Analysis, By Product Type

5.1. Introduction

5.1.1. Market Share & Basis Point Share(BPS) Analysis, By Product Type

5.1.2. Y-O-Y Growth Comparison, By Product Type

5.2. Market Forecast, By Product Type

5.2.1. Absorbable

5.2.1.1. Absolute $ Opportunity

5.2.1.2. Market Value Forecast

5.2.2. Non-absorbable

5.2.2.1. Absolute $ Opportunity

5.2.2.2. Market Value Forecast

5.3. North America and Europe Dermal Filler Market Value Forecast by Product Type, 2016-2026

6. North America and Europe Dermal Filler Market, Analysis and Forecast 2016-2026, By Distribution channel

6.1. Introduction

6.1.1. Y-O-Y Growth Comparison, By Distribution Channel

6.1.2. Market Share & Basis Point Share(BPS) Analysis, By Distribution Channel

6.2. Market Forecast, by Distribution channel

6.2.1. Retail Pharmacies and Drug Stores

6.2.1.1. Absolute $ Opportunity

6.2.1.2. Market Value Forecast

6.2.2. Clinics and Hospital Pharmacies

6.2.2.1. Absolute $ Opportunity

6.2.2.2. Market Value Forecast

6.2.3. Online Sales

6.2.3.1. Absolute $ Opportunity

6.2.3.2. Market Value Forecast

6.3. North America and Europe Dermal Filler Market Value Forecast by Distribution Channel, 2016-2026

7. North America and Europe Dermal Filler Market, Analysis and Forecast, 2016-2026, By Material type

7.1. Introduction

7.1.1. Y-O-Y Growth Comparison, By Material

7.1.2. Market Share & Basis Point Share(BPS) Analysis, By Material

7.2. Market Forecast, By Material

7.2.1. Hyaluronic Acid

7.2.1.1. Absolute $ Opportunity

7.2.1.2. Market Value Forecast

7.2.2. Poly-L-Lactic Acid

7.2.2.1. Absolute $ Opportunity

7.2.2.2. Market Value Forecast

7.2.3. Calcium Hydroxylapatite

7.2.3.1. Absolute $ Opportunity

7.2.3.2. Market Value Forecast

7.2.4. Polymethylmethacrylate

7.2.4.1. Absolute $ Opportunity

7.2.4.2. Market Value Forecast

7.2.5. Collagen

7.2.5.1. Absolute $ Opportunity

7.2.5.2. Market Value Forecast

7.3. Market Attractiveness Analysis, By Material type

7.4. Recently Approved or Launched Dermal Fillers

8. North America and Europe Dermal Filler Market, Analysis and Forecast 2016-2026, By Region

8.1. Introduction

8.1.1. Market share and Basis Point (BPS) Analysis, By Region

8.1.2. Market attractiveness analysis By Region

8.1.3. Y-O-Y Growth Projections, by Region

8.2. Market Absolute $ opportunity, By Region

8.2.1. North America Market Absolute $ opportunity

8.2.2. Western Europe Market Absolute $ opportunity

8.2.3. Eastern Europe Market Absolute $ opportunity

8.3. Market Value forecast, By Region

9. North America Dermal Filler Market, Analysis and Forecast 2016-2026

9.1. Introduction

9.1.1. Market share and Basis Point (BPS) Analysis, By Country

9.1.2. Market attractiveness analysis By Country

9.1.3. Y-O-Y Growth Projections, by Country

9.2. North America Dermal Filler Market Value Forecast, By Country

9.3. North America Dermal Filler Market Value Forecast, By Product Type

9.4. North America Dermal Filler Market Value Forecast, By Distribution Channel

9.5. North America Dermal Filler Market Value Forecast, By Material Type

9.6. North America Dermal Filler Market Attractiveness Analysis

9.6.1. North America Dermal Filler Market Attractiveness Analysis, By Product Type

9.6.2. North America Dermal Filler Market Attractiveness Analysis, By Distribution Channel

9.6.3. North America Dermal Filler Market Attractiveness Analysis, By Material Type

9.7. North America Dermal Filler Market Trends

9.8. Drivers and Restraints Impact Analysis

10. Western Europe Dermal Filler Market, Analysis and Forecast, 2016-2026

10.1. Introduction

10.1.1. Market share and Basis Point (BPS) Analysis, By Country

10.1.2. Market attractiveness analysis By Country

10.1.3. Y-O-Y Growth Projections, by Country

10.2. Western Europe Dermal Filler Market Value Forecast, By Country

10.3. Western Europe Dermal Filler Market Value Forecast, By Product Type

10.4. Western Europe Dermal Filler Market Value Forecast, By Distribution Channel

10.5. Western Europe Dermal Filler Market Value Forecast, By Material Type

10.6. Western Europe Dermal Filler Market Attractiveness Analysis

10.6.1. Western Europe Dermal Filler Market Attractiveness Analysis, By Product Type

10.6.2. Western Europe Dermal Filler Market Attractiveness Analysis, By Distribution Channel

10.6.3. Western Europe Dermal Filler Market Attractiveness Analysis, By Material Type

10.7. Western Europe Dermal Filler Market Trends

10.8. Drivers and Restraints Impact Analysis

11. Eastern Europe Dermal Filler Market, Analysis and Forecast 2016-2026

11.1. Introduction

11.1.1. Market share and Basis Point (BPS) Analysis, By Country

11.1.2. Market attractiveness analysis By Country

11.1.3. Y-O-Y Growth Projections, by Country

11.2. Eastern Europe Dermal Filler Market Value Forecast, By Country

11.3. Eastern Europe Dermal Filler Market Value Forecast, By Product Type

11.4. Eastern Europe Dermal Filler Market Value Forecast, By Distribution Channel

11.5. Eastern Europe Dermal Filler Market Value Forecast, By Material Type

11.6. Eastern Europe Dermal Filler Market Attractiveness Analysis

11.6.1. Eastern Europe Dermal Filler Market Attractiveness Analysis, By Product Type

11.6.2. Eastern Europe Dermal Filler Market Attractiveness Analysis, By Distribution Channel

11.6.3. Eastern Europe Dermal Filler Market Attractiveness Analysis, By Material Type

11.7. Eastern Europe Dermal Filler Market Trends

11.8. Drivers and Restraints Impact Analysis

12. Company Profiles

12.1. Galderma Pharma S.A.

12.2. Sinclair Pharma plc.

12.3. Allergan Plc.

12.4. Anika Therapeutics Inc.

12.5. Merz Pharma GmbH & Co. KGaA

12.6. Suneva Medical Inc.

12.7. Teoxane Laboratories Inc.

12.8. Prollenium Medical Technologies Inc.

12.9. Adoderm GmbH

12.10. Laboratoires Vivacy SAS



【レポートのキーワード】

ダーマルフィラー、皮膚充填剤

★調査レポート[ダーマルフィラー(皮膚充填剤)の北米・欧州市場2016-2026] (コード:FMI703010)販売に関する免責事項を必ずご確認ください。
★調査レポート[ダーマルフィラー(皮膚充填剤)の北米・欧州市場2016-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆